Realmind Biotech raises $7.4M Series C, moves diagnostics production to Huangshan
What's the deal? Realmind BiotechDealroom has a profile for this one. Try Dealroom → (Nanjing Realmind Biotechnology) has raised US$6.88M in a Series C round announced in September 2026. Huangshan Jiantou Group led through a dedicated fund set up with Hanyuan CapitalDealroom has a profile for this one. Try Dealroom →, with Anfulan Capital's Huangshan Strategic New Fund following on.
What does the company do? Realmind is a national-level high-tech firm focused on chemiluminescence immunoassay for in-vitro diagnostics. It holds domestic core technology for direct whole-blood and peripheral-blood chemiluminescence testing, targeting the "old and young" health market across acute care, thrombosis, Alzheimer's, child development, and reproductive health.
What's the money for? Realmind will set up in Huangshan, building a chemiluminescence immunoassay reagent line and home-testing device line under a total project investment of US$8.25M.
Why Huangshan? The city has built up wellness tourism but long leaned on services over manufacturing, leaving high-end medical device production weak. Local officials frame the deal as linking innovative diagnostics with wellness scenarios, tying home health testing to the region's tourism and care resources.
The parallel push: Days later, on September 21, a brain-computer interface project from Anhui Fuqing MedicalDealroom has a profile for this one. Try Dealroom → went into production in Huizhou district. Huangshan Jiantou and Huizhou District Investment GroupDealroom has a profile for this one. Try Dealroom → each committed US$3.44M through a special-purpose vehicle, backing a project with total planned investment of US$13.8M.
The signal: Huangshan is using state capital as an investor rather than a subsidiser, shifting from chasing any investment to picking science-led projects. Since its 2023 restructuring, Huangshan Jiantou has backed firms including GuangyangDealroom has a profile for this one. Try Dealroom →, Ruichang InternationalDealroom has a profile for this one. Try Dealroom →, Innovusion, and now Realmind — part of a broader move to make public capital the lever for regional industrial upgrading.
Read more: sohu.com
Image credit: Generated with Gemini
